Bio-Gate AG filed its Annual on Apr 07, 2022 for the period ending Dec 31, 2021. In this report its auditor, Rödl & Partner GmbH - Roedl & Partner Audit SRL, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 EUR | -2.00% | -2.00% | -7.55% |
2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.55% | 9.67M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- BIG1 Stock
- News Bio-Gate AG
- Bio-Gate AG Auditor Raises 'Going Concern' Doubt